Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Global Market for Blood Banking and Blood Products Projected to reach $43 billion by 2018; Spectrometers and Fluorometers to Reach $18.4 bn; Anticoagulants to Reach $12.9 bn; Cell and Tissue Culture Supplies to Reach $5.6 bn

FARMINGTON, Conn., Nov. 6, 2012 /PRNewswire-iReach/ -- Four innovating life science fields to keep an eye on include blood banking, spectrometry, anticoagulants, and cell and tissue culture. Thanks to an aging population and a steep increase in healthcare expenditures among other trends, these markets are on the rise.

(Photo: http://photos.prnewswire.com/prnh/20121106/CG07120)

Global Information Inc (GII) presents four innovative life science market research reports from our premium research partner Global Industry Analysts, Inc. These global strategic business reports provide market forecasts, profile key companies and players, and review mergers, acquisitions and other strategic industry activities related to the dynamic markets for spectrometers, cell and tissue cultures, anticoagulants and blood banking.

Spectrometers and Spectrophoto/Fluorometers

Spectroscopic instruments are the swiss army knife of laboratories – they perform diverse tasks such as monitoring processes, identifying compounds and elucidating chemical structures. Driven by rising sales of instrument systems by laboratories, the market for spectroscopy instruments recovered in 2010 and experienced a strong resurgence in 2011 and is project to reach $18.4 billion by the year 2018.

Developed markets such as the United States, Europe and Japan account for a predominant share of the global market for spectrometers and spectrophoto/fluorometers. Despite the continued dominance of developed regions, emerging economies specifically in Asia-Pacific, such as India and China, and Latin America are expected to offer newer opportunities owing to the different economics as well as application needs.

In the long run, demand from industries such as metals, chemicals and automotive is expected to continue driving growth in the spectroscopy market. Advancements in the areas of drug discovery and development, metabolomics, pharmacogenomics, and expanded application markets bode well for the future of spectroscopy market. Above average demand is also expected from security and defense industries; research targeted at discovery and use of new materials as well as continued growth in applications suitable for use in the life sciences market. Advanced spectrometers of the future will target the emerging demands of areas such as mineralogy, medicine, environment, pharmaceuticals and biochemistry.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go134266-spectrometers.html

Cell/Tissue Culture Supplies

The global market for Cell/Tissue Culture Supplies is projected to reach US$5.6 billion by 2018, driven by advances in biotechnology and life science research coupled with broader range of application areas. Going forward, the market for Cell/Tissue Culture Supplies is expected to grow at an impressive pace, fueled by heightened interest in biopharmaceutical therapeutics, human and veterinary vaccine applications, and growing success of industrial biopharmaceuticals.

The evolution of cell culture technologies witnessed the successful incorporation of a number of segments such as cell biology, genetic engineering, protein chemistry, genomics and chemical engineering into the cell culture field, thus serving to enrich the cell/tissue culture domain. Growing awareness about applications of biotherapeutics is driving the market for products from cell cultivation. Cells play a major role in the development of biopharma drugs such as therapeutic enzymes, monoclonal antibodies (mABs), interferons, vaccines, thrombolytics, blood factors and hormones for treating life-threatening diseases.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go138765-cell-tissue-culture.html

Anticoagulants

The anticoagulants market has come a long way since the 1990s. With thrombosis emerging as one of the major causes of death in various countries across the world, regulation of blood clotting has become one of the key areas of focus in the medical fraternity in recent times. The global market for anticoagulants is projected to reach US$12.9 billion by the year 2018, primarily driven by growing population at the risk of thrombosis. Aging population, rising incidence of cardiovascular diseases, acute hip and knee complications and the emergence of novel oral therapeutics also comprise the key factors supporting market growth.

This report provides a comprehensive review of trends, review of new drugs, indications, comparative data on select drugs, drug development pipeline, product approvals/introductions, strategic industry activities and profiles of major companies worldwide. Major players profiled in the report include Bayer Healthcare AG, Boehringer Ingelheim, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd., among others.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go138649-anticoagulants.html

Blood Banking and Blood Products

The global market for Blood Banking and Blood Products is projected to reach US$43 billion by 2018, driven by health scares and regulatory requirements. Worldwide market for Blood Banking and Blood Products is exhibiting a healthy trend, thanks to an aging population, and a steep increase in healthcare expenditures.

Though temporarily impacted by the economic recession, new infections continue to take a toll on population in developing nations, fueling demand for blood banking and blood products. Regulatory and healthcare bodies across the world, in a bid to serve these people, are adopting stringent policies relating to blood safety. As an extension to this, manufacturers all over the world are developing improved, safer, and advanced blood banking technologies for the collection, processing and delivery of blood products.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go136179-blood-banking.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Yuko Ueki Global Information, Inc., 860-674-8796, US-marketing@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Information Inc.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
Machine-to-machine (M2M) technology and the resulting Internet of Things are leading us inexorably toward everything-as-a-service (XaaS). As more things get connected, the range of service opportunities expands. And as those services are presented online, they become available for use,...
General Electric (GE) has been a household name for more than a century, thanks in large part to its role in making households easier to run. Starting with the light bulb invented by its founder, Thomas Edison, GE has been selling devices (“things”) to consumers throughout its 122-year...
With the growing number of CSS Preprocessors like LESS, Sass, Turbine, Stylus and Swith CSS to name a few, it’s hard to decide which to choose for your project, and which will provide the best CSS authoring. Rather than focus on evaluating every CSS Preprocessor (that would simply take...
In my hunt for the mysterious DevOps practice, I’ve been let down. DevOps are hard to find. When you find them, they do not exactly do what you think they should do. Some DevOps teams only execute on automation for dev; while others are operations folks with a new name; and still other...
Just last year, a CA Technologies and Vanson Bourne survey revealed that DevOps was not a sure-fire hit— 16 percent of senior IT professionals did not know what DevOps was, and an additional 18 percent had no plans to adopt it. Fast forward one year and the results tell an entirely new...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE